To confirm the clinical relevance of the CD39-dependent mechanism in NSCLC-induced T cell mal-differentiation, healthy CD4+ T cells were pre-incubated with patient-derived primary NSCLC cells and activated with anti-CD3/CD28 beads in the presence or absence of ARL67156. This evidence concerns the gene CD4 and non-small cell lung carcinoma.